Catabasis Pharmaceuticals competitors

Catabasis Pharmaceuticals Competitors include Opiant Pharmaceuticals, Vitality Biopharma, Mylan and Amphastar Pharmaceuticals.
Add company...
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals
Catabasis Pharmaceuticals discovers and develops innovative drugs for treating inflammatory conditions.
Opiant Pharmaceuticals
Opiant Pharmaceuticals
Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.
Vitality Biopharma
Vitality Biopharma
Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.
Mylan
Mylan
Mylan offers generic and specialty pharmaceutical products.
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals
A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.
Founding Date
Founding Date
2008
Founding Date
2009
Founding Date
2012
Founding Date
1961
Founding Date
1996
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Santa Monica, US HQ
Locations
Los Angeles, US HQ
Locations
Canonsburg, US HQ
Hertfordshire, GB
Locations
Rancho Cucamonga, US HQ
Employees
Employees
365% decrease
Employees
3
Employees
7
Employees
35,000
Employees
1,6447% increase
Valuation ($)
Valuation ($)
42.1 m
Valuation ($)
58.5 m
Valuation ($)
38.8 m
Valuation ($)
15 b
Valuation ($)
936.7 m
Twitter followers
Twitter followers
250
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
7.2 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
$500k (FY, 2017)
Revenue (est.)
$18.4m (FY, 2017)
Revenue (est.)
$102.4k (FY, 2018)
Revenue (est.)
$11.8b (FY, 2017)
Revenue (est.)
$240.2m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$77.9k (FY, 2018)
Cost of goods
N/A
Cost of goods
$149.4m (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$24.5k (FY, 2018)
Gross profit
N/A
Gross profit
$90.8m (FY, 2017)
Net income
Net income
($27.4m) (FY, 2017)
Net income
$6.6m (FY, 2017)
Net income
($4.3m) (FY, 2018)
Net income
$696m (FY, 2017)
Net income
$4.5m (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Opiant Pharmaceuticals
HQ
Santa Monica, US
Employees
3

Opiant Pharmaceuticals is a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive and eating disorders.

View company
Vitality Biopharma
HQ
Los Angeles, US
Employees
7

Vitality Biopharma is a cure development company, and dedicated to unlocking the power of cannabinoids for treatment of serious neurological and inflammatory conditions.

View company
Mylan
HQ
Canonsburg, US
Employees
35,000

Mylan offers generic and specialty pharmaceutical products.

View company
Amphastar Pharmaceuticals
HQ
Rancho Cucamonga, US
Employees
1,644↑ 7% increase

A specialty pharmaceutical company engaged in the development, manufacturing and marketing of generic and proprietary injectable and inhalation products.

View company